E3 PreliminaryModerate confidencePEM ✓MechanisticPeer-reviewedMachine draft
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
Fluge, Øystein, Mella, Olav, Bruland, Ove et al. · JCI insight · 2016 · DOI
Quick Summary
This study found that people with ME/CFS have abnormal patterns of amino acids (building blocks of protein) in their blood, suggesting their bodies struggle to produce energy efficiently through normal metabolic pathways. The research identified a specific problem with an enzyme called pyruvate dehydrogenase that helps convert fuel into cellular energy, and showed that cells from ME/CFS patients produce excess lactate (a byproduct of incomplete energy metabolism) when stressed. These findings help explain why ME/CFS patients experience exhaustion after exertion and poor recovery.
Why It Matters
This study provides evidence for a specific, measurable metabolic mechanism underlying ME/CFS symptoms—particularly postexertional malaise and fatigue—rather than attributing symptoms to deconditioning or psychological factors. Identifying pyruvate dehydrogenase dysfunction as a potential therapeutic target offers a biological framework for developing treatments. These findings validate patient reports of energy metabolism problems and could guide development of metabolic interventions.
Observed Findings
- Serum amino acids fueling oxidative metabolism were selectively reduced, especially in female ME/CFS patients
- Serum 3-methylhistidine (marker of muscle protein breakdown) was significantly elevated in male ME/CFS patients
- Peripheral blood mononuclear cells showed increased expression of pyruvate dehydrogenase kinases 1, 2, and 4; SIRT4; and PPARδ in both sexes
- Myoblasts exposed to serum from severely affected ME/CFS patients displayed enhanced mitochondrial respiration coupled with excessive lactate secretion
- Metabolic amino acid patterns were independent of symptom severity, disease duration, age, BMI, and physical activity level
Inferred Conclusions
- ME/CFS is associated with functional impairment of pyruvate dehydrogenase, leading to inadequate ATP generation through oxidative phosphorylation
- The disease involves a shift toward anaerobic metabolism with lactate overproduction during exertion, consistent with postexertional malaise
- Circulating serum factors in ME/CFS patients induce metabolic adaptations in patient-derived cells, suggesting humoral mechanisms
- The metabolic disturbances are a biological feature of ME/CFS pathophysiology rather than secondary to symptom severity or deconditioning
Remaining Questions
What This Study Does Not Prove
This study demonstrates associations between metabolic markers and ME/CFS diagnosis but does not prove that pyruvate dehydrogenase dysfunction is the primary cause of the disease or sufficient to cause all symptoms. The findings are observational and correlational; it remains unclear whether the metabolic changes drive disease pathogenesis or represent secondary adaptations to an underlying process. The study does not establish whether these metabolic abnormalities are present in all ME/CFS patients or are disease-specific rather than found in other conditions.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:MetabolomicsGene ExpressionBlood Biomarker
Phenotype:Severe
Method Flag:Strong PhenotypingSevere ME IncludedSex-Stratified
Metadata
- DOI
- 10.1172/jci.insight.89376
- PMID
- 28018972
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026